If you had invested $1000 in Becton Dickinson 10 years ago, your investment would be worth over $40000 today.

Trending News ☀️

Becton ($NYSE:BDX) Dickinson is a medical technology company that manufactures and sells medical devices, instruments, and reagents. The company’s strong financial performance and favorable outlook have made its stock one of the best performers on the market over the past 10 years. Becton Dickinson’s products are used in a wide variety of medical applications, and its products are highly regarded by customers and physicians alike. The company’s products are used in hospitals, clinics, and laboratories around the world.

Price History

The company has been in the news recently due to its positive media exposure and strong stock performance. On Monday, BECTON stock opened at $234.6 and closed at $236.0, up by 0.3% from last closing price of 235.3.

VI Analysis

Becton, Dickinson and Company is a medical technology company that manufactures and sells medical devices, instruments, and reagents. The company operates in three segments: BD Medical, BD Biosciences, and BD Interventional. BD Medical segment offers products and services for the prevention and treatment of infectious diseases, as well as for use in diabetes care, point-of-care testing, and pharmacy automation. BD Biosciences segment provides products and services for the research, diagnosis, and treatment of cancer and other diseases.

BD Interventional segment offers products and services for the diagnosis and treatment of cardiovascular diseases and other conditions. Based on the VI Risk Rating, Becton is a medium risk investment in terms of financial and business aspects. The company has a few risk warnings in its income sheet and balance sheet, but overall is a stable company with a long history of success.

VI Peers

Becton, Dickinson and Co is a medical technology company that manufactures and sells medical devices, instruments, and supplies. The company operates in three segments: BD Medical, BD Biosciences, and BD Diagnostics. It offers a wide range of products, including syringes, needles, catheters, blood collection devices, IV administration and infusion products, safety products, and sharps disposal systems. The company competes with Penumbra Inc, Teleflex Inc, SheerVision Inc, and other medical technology companies.

– Penumbra Inc ($NYSE:PEN)

Founded in 2002, Umbra is a leading global provider of shading and decorative products. The company’s products are sold in over 120 countries and include a wide range of blinds, shades, drapery hardware, and curtain rods. Headquartered in Toronto, Canada, Umbra employs over 1,200 people worldwide.

Umbra’s market cap is 7.01B as of 2022. The company’s Return on Equity is -2.31%.

The company’s products are sold in over 120 countries and include a wide range of blinds, shades, drapery hardware, and curtain rods.

– Teleflex Inc ($NYSE:TFX)

Teleflex Incorporated is a diversified global provider of medical technologies designed to improve the health and quality of people’s lives. The Company provides solutions for critical care, anesthesia, surgical, urology and emergency medicine.

– SheerVision Inc ($OTCPK:SVSO)

SheerVision Inc is a US-based company that manufactures and sells ophthalmic surgical instruments and devices. The company has a market cap of 140.32k as of 2022 and a Return on Equity of -70.28%. SheerVision’s products are used by eye surgeons to correct vision problems such as nearsightedness, farsightedness, and astigmatism. The company’s products are sold through a network of distributors and retailers worldwide.

Summary

This is thanks to the company’s strong financial performance and favorable media exposure. Becton Dickinson is a leading medical technology company that manufactures and sells a variety of medical devices and supplies. Its products are used in hospitals, clinics, and laboratories around the world. The company has a strong track record of delivering shareholder value, and its stock has outperformed the market in recent years.

Investors in Becton Dickinson have been rewarded with strong returns, and the company is well-positioned for continued success in the future. Thanks to its strong financial performance and favorable media exposure, Becton Dickinson is an attractive investment option for those looking to profit from the medical technology sector.